The Good
- Flat-Rate Pricing: $249/$299 rates are locked and do not increase with dosage.
- Transparency: Clearly discloses 503A pharmacy partners (Promise and Foothills).
- Cost Structure: No membership fees, hidden fees, or long-term contracts.
- LegitScript Certified: Verified legitimacy despite regulatory warnings.
The Bad
- Regulatory Warning: Received FDA Warning Letter in Sept 2025 for misbranding.
- Customer Support: Severe issues reported with responsiveness and phone lines.
- Logistics: Recent verified reports of shipping delays exceeding 2 weeks.
- Availability: Does not serve major markets like California, plus AL, AR, LA, MS, ND.
Why We Chose Sprout Health
Sprout Health distinguishes itself in the crowded telehealth market primarily through its pricing architecture. For patients requiring higher therapeutic doses of GLP-1 medications, Sprout offers one of the most competitive value propositions available. While many providers charge upwards of $400 for 2.4mg of Semaglutide or 15mg of Tirzepatide, Sprout’s flat-rate model ($249/$299) ensures cost predictability. Furthermore, their transparency regarding pharmacy partners—specifically naming Promise Pharmacy and Foothills Professional Pharmacy—provides a layer of safety assurance that is often missing in the industry. The lack of membership fees and the month-to-month flexibility make it a low-risk financial entry point for patients new to GLP-1 therapy.
The Patient Experience
While the financial model is attractive, the operational execution presents significant risks. The patient journey typically begins with a seamless and rapid digital intake, often resulting in approval within 24 hours. However, the post-purchase experience is marred by inconsistent logistics. Recent verified reports from late 2025 highlight a trend of shipping delays and a non-responsive customer support team. Patients should be aware that while the medication is sourced from legitimate 503A pharmacies, the administrative interface (Sprout Health) struggles with communication. Additionally, the September 2025 FDA Warning Letter regarding their marketing claims suggests a need for caution regarding the company's advertising accuracy.
Verified Customer Reviews
"I am filing this complaint regarding an order I placed with Sprouts Health on November 22, 2025... As of today, December 9, 2025, the prescription has still not been mailed... I sent eight (8) emails requesting updates."
"Stay away from Sprouts Health-it's a scam... As of today, December 9, 2025, the prescription has still not been mailed... still shows 'not shipped'."
"Second order was Dec 1 and it just arrived yesterday (1week later) even with overnight shipping. I sent them a helpdesk message last week - no reply."